 Connection
Amy Sato to Osteoporosis
This is a "connection" page, showing publications Amy Sato has written about Osteoporosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.718 |
|
|
|
-
Sato AY, Cregor M, Delgado-Calle J, Condon KW, Allen MR, Peacock M, Plotkin LI, Bellido T. Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin. J Bone Miner Res. 2016 10; 31(10):1791-1802.
Score: 0.458
-
Wang X, Sato AY, Marino S, Akel N, Boysen G, Basnakian AG, Bellido TM, Li HY. Generation of BT-Amide, a Bone-Targeted Pyk2 Inhibitor, Effective via Oral Administration, for the Prevention of Glucocorticoid-Induced Bone Loss. J Med Chem. 2024 Nov 28; 67(22):20708-20720.
Score: 0.206
-
James A, Hendrixson JA, Kadhim I, Marques-Carvalho A, Laster J, Crawford J, Thostenson J, Wanchai V, Sato AY, Nookaew I, Xiong J, Almeida M, Onal M. Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength. JCI Insight. 2025 Sep 09; 10(17).
Score: 0.054
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|